Solid Biosciences (SLDB) Leases (2019 - 2024)
Solid Biosciences (SLDB) has disclosed Leases for 6 consecutive years, with $24.9 million as the latest value for Q3 2024.
- Quarterly Leases fell 8.57% to $24.9 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $24.9 million through Sep 2024, down 8.57% year-over-year, with the annual reading at $26.5 million for FY2023, 8.32% down from the prior year.
- Leases hit $24.9 million in Q3 2024 for Solid Biosciences, down from $25.5 million in the prior quarter.
- In the past five years, Leases ranged from a high of $28.9 million in Q4 2022 to a low of $722000.0 in Q1 2022.
- Historically, Leases has averaged $15.6 million across 5 years, with a median of $24.9 million in 2024.
- Biggest five-year swings in Leases: tumbled 77.41% in 2022 and later skyrocketed 3820.5% in 2023.
- Year by year, Leases stood at $3.6 million in 2020, then plummeted by 68.09% to $1.1 million in 2021, then surged by 2434.94% to $28.9 million in 2022, then dropped by 8.32% to $26.5 million in 2023, then decreased by 6.33% to $24.9 million in 2024.
- Business Quant data shows Leases for SLDB at $24.9 million in Q3 2024, $25.5 million in Q2 2024, and $26.1 million in Q1 2024.